Trial Profile
A Multicenter, Randomized Clinical Investigation of Trelstar Versus Continued Therapy in Patients Receiving Lupron or Zoladex for Advanced Prostate Cancer
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary) ; Leuprorelin (Primary) ; Triptorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 27 Apr 2016 New trial record